Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2A, Randomized, Stratified, Observer-Blind Study to Evaluate the Immunogenicity and Safety of mRNA-1283 Vaccine Boosters for SARS-CoV-2

NCT05137236 is registered in ClinicalTrials.gov with ModernaTX, Inc. as lead sponsor.

NCT NCT05137236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05137236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2A, Randomized, Stratified, Observer-Blind Study to Evaluate the Immunogenicity and Safety of mRNA-1283 Vaccine Boosters for SARS-CoV-2
Lead sponsor
ModernaTX, Inc.
Phase
Phase 2
Overall status
Completed
Start date
December 6, 2021
Completion date
March 23, 2023
Enrollment
540 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2